|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| A61M 5/178 | |||
| C07K 1/00 | |||
| C07K 16/00 |
| (11) | Number of the document | 3226895 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15805446.0 |
| Date of filing the European patent application | 2015-12-03 | |
| (97) | Date of publication of the European application | 2017-10-11 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-22 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2015/078482 |
| Date | 2015-12-03 |
| (87) | Number | WO 2016/087569 |
| Date | 2016-06-09 |
| (30) | Number | Date | Country code |
| 14196069 | 2014-12-03 | EP |
| (72) |
PEDRUSSIO, Renzo, CH
STYGER, Regula, CH
|
| (73) |
CSL Behring AG,
Wankdorfstrasse 10, 3014 Bern,
CH
|
| (54) | PHARMACEUTICAL PRODUCT WITH INCREASED STABILITY COMPRISING IMMUNOGLOBULINS |
| PHARMACEUTICAL PRODUCT WITH INCREASED STABILITY COMPRISING IMMUNOGLOBULINS |